Answers are grounded in this paper and cite their sources.
Evaluates drug delivery and tumor control in colorectal cancer stem cells, indicating effective personalized treatment options.
when choosing the drug oxaliplatin rather than DOXO and applying MHT. These findings emphasize the potential of our nanoplatforms as an effective patient-personalized cancer treatment against qCR-CSCs.
No takes yet. Share an insight, caveat, or question.
Fernandes et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: